• Silicon Valley hoped the Khashoggi story would go away; instead, it may end an era

    29 days ago - By Tech Crunch

    It's amazing how quickly things can change. Exactly a week ago, we wondered if Saudi Arabia's money might finally become radioactive in light of the disappearance of Saudi journalist and Washington Post columnist Jamal Khashoggi. Almost no one who we reached for comment wanted to participate in the story, though behind the scenes, we heard the same things from different sources who have a vested interest in keeping the peace with the country and its Crown Prince Mohammed bin Salman: There is no proof. We're waiting to see what happens. You're naive if you think this is the only regime that...
    Read more ...

     

  • The CEO of Silicon Valley DNA testing startup 23andMe shares the health product she hopes to sell next

    The CEO of Silicon Valley DNA testing startup 23andMe shares the health product she hopes to sell next

    29 days ago - By Business Insider

    Anne Wojcicki, the CEO and founder of Silicon Valley's most popular genetics testing startup, 23andMe, said this week that she hopes the company expands its current health offering lineup.
    23andMe, which made headlines recently on the heels of a new $300-million partnership with drug giant GlaxoSmithKline , currently offers health screenings for some of the genes involved in breast cancer, Alzheimer's, and Parkinson's.
    On Tuesday, Wojcicki said she hopes to add a new mental health screening that looks at how you process depression medications.
    Albertsons pharmacies and gene testing startup...
    Read more ...

     

  • The CEO of Silicon Valley DNA testing startup 23andMe shares the health product she hopes to sell next

    The CEO of Silicon Valley DNA testing startup 23andMe shares the health product she hopes to sell next

    29 days ago - By Business Insider

    Anne Wojcicki, the CEO and founder of Silicon Valley's most popular genetics testing startup, 23andMe, said this week that she hopes the company expands its current health offering lineup.
    23andMe, which made headlines recently on the heels of a new $300-million partnership with drug giant GlaxoSmithKline , currently offers health screenings for some of the genes involved in breast cancer, Alzheimer's, and Parkinson's.
    On Tuesday, Wojcicki said she hopes to add a new mental health screening that looks at how you process depression medications.
    Albertsons pharmacies and gene testing startup...
    Read more ...